It has reached the top

Editorial Board

33 Editors in 9 Countries/Region

Italy (14)
USA (9)
Portugal (2)
China (2)
Spain (2)
United Kingdom (1)
Switzerland (1)
South Korea (1)
Germany (1)

Honorary Editors-in-Chief

Christopher D. Byrne

Endocrinology & Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK.

Research Interests: liver lipid metabolism, endocrinology, dyslipidaemias, metabolic liver disease, type 2 diabetes, NAFLD


Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

Giovanni Targher

Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Research Interests: nonalcoholic fatty liver disease, type 2 diabetes, insulin resistance, metabolic syndrome, cardiovascular disease, chronic kidney disease


Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

PNPLA3 rs738409 polymorphism and kidney dysfunction: an association beyond nonalcoholic fatty liver disease?

Special Issue:

Inter-relationships Between COVID-19 and Metabolic Disorders

Associate Editors

Luigi Elio Adinolfi

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Miraglia, Naples, Italy.

Research Interests: intrahepatic cholestasis, HCV cryoglobulinemia, chronic viral hepatitis, NAFLD, HCC

Pietro Andreone

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Research Interests: chronic hepatitis, cirrhosis, hepatocellular carcinoma, liver immunology, liver transplantation, liver stem cells


Liver transplantation and nonalcoholic steatohepatitis: the state of the art

Gyorgy Baffy

Department of Medicine, VA Boston Healthcare System and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Research Interests: nonalcoholic fatty liver disease, metabolic dysfunction-associated liver disease, steatohepatitis, portal hypertension, cirrhosis


Mechanobiology in the development and progression of nonalcoholic fatty liver disease: an updated review

Special Issue:

Mechanosignaling Pathways in Metabolic Dysfunction

Stefano Bellentani

Consultant Gastroenterologist and Hepatologist, Italian Liver Foundation, Basovizza, Italy.

Research Interests: NAFLD, NASH, epidemiology, chronic viral hepatitis, irritable bowel syndrome, inflammatory bowel disease, metabolic disease


The Fatty liver Index (FLI) 15 years later: a reappraisal

Helena Cortez-Pinto

Faculdade de Medicina de Lisboa, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.

Research Interests: NASH trials, metabolism, nutrition

Leonardo M. Fabbri

Department of Morphology, Surgery and Experimental Medicine, Section of Respiratory Diseases, University of Ferrara, Ferrara, Italy.

Research Interests: respiratory diseases, metabolic medicine, endocrinology geriatrics, metabolism

Silvia R. Fargion

Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Milan, Italy.

Research Interests: metabolic and virus liver diseases (MAFLD, NAFLD, HCV and HBV chronic hepatitis), vascular disorders in metabolic liver diseases, iron and copper induced liver diseases (hemochromatosis, Wilson disease)


Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system

Giampiero Francica

Interventional Ultrasound Unit, Pineta Grande Hospital, Castel Volturno, Italy.

Research Interests: ultrasound, diagnostic, biopsy and ablation of liver tumors

Special Issue:

Metabolism and Cancer

Fulvio Lonardo

Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.

Research Interests: morphological, molecular, epidemiological, thoracic malignancies


Metabolism and cancer-select topics

Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?

Luca Roncucci

Department of Maternal, Child and Adult Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: colorectal carcinogenesis, hereditary colorectal cancer, inflammation, chemoprevention of tumors


Colon cancer in a 12-year-old girl with hypertriglyceridemia

Special Issue:

Metabolism and Cancer

Ayako Suzuki

Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA.

Research Interests: NAFLD, NASH, biological disparities, sex differences, gender differences, drug-induced liver injury, hepatotoxicity


Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Special Issue:

Sex Differences in Dysmetabolic Organ Damage and Senescence

Claudio Tiribelli

Fondazione Italiana Fegato-ONLUS, Trieste, Italy.

Research Interests: fatty liver and associated diseases, liver damage, stem cells in HCC, personalized treatment, NAFLD


Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

The Fatty liver Index (FLI) 15 years later: a reappraisal

Editorial Board Members

Juan Pablo Arab

Department of Medicine, Division of Gastroenterology and Hepatology, Western University, Ontario, Canada.

Research Interests: nonalcoholic fatty liver disease, MAFLD, NAFLD, steatosis, fatty liver, alcohol, alcohol-associated liver disease


Sarcopenia in the setting of nonalcoholic fatty liver

Colorectal adenomas and MAFLD: a cross-sectional study in a Hispanic screening cohort

Annalisa Berzigotti

Swiss Liver Center, Visceral Surgery and Medicine Clinic (UVCM), Inselspital, University of Bern, Berne, Switzerland.

Research Interests: portal hypertension, non-invasive assessment of liver disease, obesity and liver disease

Fernando Bril

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Research Interests: insulin resistance, NAFLD, NASH, liver steatosis, fatty liver disease, lipotoxicity


Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients

Weiyi Fang

Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, Guangdong, China.

Research Interests: tumor pharmacology, tumor pathogenesis, nanomaterial drug

Águeda González-Rodríguez

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), Madrid, Spain.

Research Interests: liver, metabolism, NAFLD, fibrosis, insulin resistance, hepatocytes


Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Giovanni Guaraldi

Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: HIV, immune-metabolism, NAFLF/MAFLD, lipodystrophy, aging, solid organ transplant, COVID-19

Youngmi Jung

Department of Biological Sciences, College of Natural Science, Pusan National University, Pusan, South Korea.

Research Interests: liver fibrosis, liver regeneration, stem cell therapy, cellular reprogramming, nonalcoholic fatty liver disease


Sex disparity in the liver regeneration focusing on sex hormones

Tatiana Y Kostrominova

Department of Anatomy and Cell Biology, Indiana University School of Medicine Northwest, Indianapolis, USA.

Research Interests: skeletal muscle, tendon, aging, denervation, obesity, myokines

Mariana Machado

Department of Gastroenterology and Hepatology, Hospital de Vila Franca de Xira, Lisbon, Portugal.

Research Interests: non-alcoholic/metabolic dysfunction-associated fatty liver disease, alcohol-associated liver disease, liver cirrhosis, end-stage liver disease, pathophysiology of liver disease


What should we advise MAFLD patients to eat and drink?

MAFLD under the lens: the role of gut microbiota

MariaLuz Martinez-Chantar

Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia, Spain.

Research Interests: liver disease, mechanism, metabolism, post-translational modifications, translational science

Chiara Mussi

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Civil Hospital, Modena, Italy.

Research Interests: lipid-lowering drugs, osteoporotic, cardiology, atrial fibrillation, dementia, older patients

Special Issue:

The Aging Cardio-metabolism: Can we Manage the Challenges of Becoming Oldest Old?

Laura Nagy

Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH, USA.

Research Interests: alcohol-associated liver disease, macrophage biology, inflammation, cell death mechanisms, NAFLD/NASH


Diminished function of cytotoxic T- and NK- cells in severe alcohol-associated hepatitis

Sonia Najjar

Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.

Research Interests: insulin clearance, insulin metabolism, lipid metabolism, insulin resistance, inflammation, fibrosis, metabolic diseases, abdominal obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, atherosclerosis

Special Issue:

Altered Metabolism in Liver Injury

Norbert Stefan

Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, Tubingen, Germany.

Research Interests: pathophysiology of obesity and type 2 diabetes, pathophysiology and consequences of NAFLD, metabolically healthy obesity, hepatokines


Screening for advanced liver fibrosis in overweight and obese patients with NAFLD

Saula Vigili de Kreutzenberg

Department of Medicine, Division of Metabolic Diseases, University of Padova, Padova, Italy.

Research Interests: cardiovascular, NAFLD, type 2 diebetes, endocrinology, metabolic diseases

Wah Yang

Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.

Research Interests: metabolic and bariatric surgery, obesity, metabolic disorders

Special Issue:

Metabolic and Bariatric Surgery

Metabolic and Bariatric Surgery: Current Situation and Future Challenges

Jinrong Zhou

Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Research Interests: nutrition, diet, metabolic disorders, cancer prevention

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)


All published articles are preserved here permanently:


All published articles are preserved here permanently: